Literature DB >> 15123002

Basic features of hypoxic pulmonary vasoconstriction in mice.

Norbert Weissmann1, Ercan Akkayagil, Karin Quanz, Ralph Theo Schermuly, Hossein Ardeschir Ghofrani, Ludger Fink, Jörg Hänze, Frank Rose, Werner Seeger, Friedrich Grimminger.   

Abstract

Hypoxic pulmonary vasoconstriction (HPV) matches lung perfusion with ventilation which tends to optimize pulmonary gas exchange. Investigations using genetically engineered mice represent a promising approach to understand the underlying mechanisms. Our goal was to characterize basic features of HPV in the isolated buffer-perfused and ventilated mouse lung system. HPV was reproducible for several hours when ventilating the lungs with 1% O2 (10 min) alternated with normoxic ventilation periods (21% O2, 15 min). HPV was well elicitable and most constant using Krebs-Henseleit buffer with the addition of hydroxyethylamylopectin as an oncotic agent. Inhibition of both lung NO and prostanoid formation amplified HPV in an over-additive fashion. HPV was higher in BALB/c mive as compared to C57BL/6 mice, and was approximately threefold enhanced under positive pressure ventilation as compared to negative pressure ventilation. A three hour hypoxic ventilation period resulted in a biphasic vasoconstrictor response with loss of posthypoxic vasodilatation. In summary, we have characterised HPV and established an experimental set-up optimized for investigation of the basic mechanisms of HPV in mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15123002     DOI: 10.1016/j.resp.2003.10.003

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  29 in total

1.  Lysophosphatidic acid signaling protects pulmonary vasculature from hypoxia-induced remodeling.

Authors:  Hsin-Yuan Cheng; Anping Dong; Manikandan Panchatcharam; Paul Mueller; Fanmuyi Yang; Zhenyu Li; Gordon Mills; Jerold Chun; Andrew J Morris; Susan S Smyth
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-10-20       Impact factor: 8.311

2.  Discovery and pharmacological characterization of a novel potent inhibitor of diacylglycerol-sensitive TRPC cation channels.

Authors:  T Maier; M Follmann; G Hessler; H-W Kleemann; S Hachtel; B Fuchs; N Weissmann; W Linz; T Schmidt; M Löhn; K Schroeter; L Wang; H Rütten; C Strübing
Journal:  Br J Pharmacol       Date:  2015-05-19       Impact factor: 8.739

3.  Cytochrome c oxidase subunit 4 isoform 2-knockout mice show reduced enzyme activity, airway hyporeactivity, and lung pathology.

Authors:  Maik Hüttemann; Icksoo Lee; Xiufeng Gao; Petr Pecina; Alena Pecinova; Jenney Liu; Siddhesh Aras; Natascha Sommer; Thomas H Sanderson; Monica Tost; Frauke Neff; Juan Antonio Aguilar-Pimentel; Lore Becker; Beatrix Naton; Birgit Rathkolb; Jan Rozman; Jack Favor; Wolfgang Hans; Cornelia Prehn; Oliver Puk; Anja Schrewe; Minxuan Sun; Heinz Höfler; Jerzy Adamski; Raffi Bekeredjian; Jochen Graw; Thure Adler; Dirk H Busch; Martin Klingenspor; Thomas Klopstock; Markus Ollert; Eckhard Wolf; Helmut Fuchs; Valérie Gailus-Durner; Martin Hrabě de Angelis; Norbert Weissmann; Jeffrey W Doan; David J P Bassett; Lawrence I Grossman
Journal:  FASEB J       Date:  2012-06-22       Impact factor: 5.191

4.  Sensors and signals: the role of reactive oxygen species in hypoxic pulmonary vasoconstriction.

Authors:  Kimberly A Smith; Paul T Schumacker
Journal:  J Physiol       Date:  2018-08-28       Impact factor: 5.182

5.  Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange.

Authors:  Norbert Weissmann; Alexander Dietrich; Beate Fuchs; Hermann Kalwa; Mahmut Ay; Rio Dumitrascu; Andrea Olschewski; Ursula Storch; Michael Mederos y Schnitzler; Hossein Ardeschir Ghofrani; Ralph Theo Schermuly; Olaf Pinkenburg; Werner Seeger; Friedrich Grimminger; Thomas Gudermann
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-01       Impact factor: 11.205

6.  Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling.

Authors:  Peter Pokreisz; Ingrid Fleming; Ladislau Kiss; Eduardo Barbosa-Sicard; Beate Fisslthaler; John R Falck; Bruce D Hammock; In-Hae Kim; Zsolt Szelid; Pieter Vermeersch; Hilde Gillijns; Marijke Pellens; Friedrich Grimminger; Anton-Jan van Zonneveld; Desire Collen; Rudi Busse; Stefan Janssens
Journal:  Hypertension       Date:  2006-02-27       Impact factor: 10.190

7.  Inhibition of overexpressed Kv3.4 augments HPV in endotoxemic mice.

Authors:  Maurizio Turzo; Karin Metzger; Felix Lasitschka; Markus A Weigand; Cornelius J Busch
Journal:  BMC Pulm Med       Date:  2020-10-08       Impact factor: 3.317

Review 8.  NADPH oxidases-do they play a role in TRPC regulation under hypoxia?

Authors:  Monika Malczyk; Christine Veith; Ralph T Schermuly; Thomas Gudermann; Alexander Dietrich; Natascha Sommer; Norbert Weissmann; Oleg Pak
Journal:  Pflugers Arch       Date:  2015-10-01       Impact factor: 3.657

9.  Inhaled PLGA particles of prostaglandin E₁ ameliorate symptoms and progression of pulmonary hypertension at a reduced dosing frequency.

Authors:  Vivek Gupta; Nilesh Gupta; Imam H Shaik; Reza Mehvar; Eva Nozik-Grayck; Ivan F McMurtry; Masahiko Oka; Masanobu Komatsu; Fakhrul Ahsan
Journal:  Mol Pharm       Date:  2013-03-26       Impact factor: 4.939

10.  Hypoxic pulmonary vasoconstriction in the absence of pretone: essential role for intracellular Ca2+ release.

Authors:  Michelle J Connolly; Jesus Prieto-Lloret; Silke Becker; Jeremy P T Ward; Philip I Aaronson
Journal:  J Physiol       Date:  2013-06-17       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.